Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.
Introduction
Cerebrotendinous xanthomatosis (CTX)' is a rare disorder of cholesterol metabolism, inherited by an autosomal recessive pattern (1) . The most striking symptoms in CTX are tendinous xanthomas, accumulation ofsterols in the central nervous system with dementia and cerebellar ataxia, premature coronary heart disease, and gallstones (1) . Excess cholestanol (5a-cholestan-3(3-ol) is present in brain (2), xanthomas, plasma, and bile. The concentration of bile acids in the bile is subnormal, and high levels of abnormal bile alcohols are found (3, 4) . This is due to a deficient degradation of the cholesterol side chain, as shown by Salen et al. (3, 4) . 1 . Abbreviations used in this paper: CrX, cerebrotendinous xanthomatosis; HPLC, high pressure liquid chromatography; m/e, mass to charge ratio; MEM, minimal essential medium; R., retention time; TMS, trimethylsilyl.
On the basis of our previous studies in vitro (5) and in vivo (6) , we have proposed that the underlying defect is a deficiency of the mitochondrial C27-steroid 26-hydroxylase. Our findings are also consistent with the concept that the "26-hydroxylation pathway" is the major pathway for bile acid synthesis (7) . However, a different metabolic defect has been postulated by Salen et al. These workers suggest that the specific enzymatic defect in CTX is at the microsomal 24fl-hydroxylation of 5(3-cholestane3a,7a,12a,25-tetrol (8, 9) . This would be compatible with their proposal that the "25-hydroxylation pathway" may be, physiologically, the most important route for the formation of bile acids (10) . Recently, Salen' s group has also found evidence for depressed 26-hydroxylation in CTX (11) , and they conclude that the primary enzymatic defect in this disease remains to be established (1 1) .
In the present study, we show the presence ofC27-steroid 26-hydroxylase in cultured skin fibroblasts from healthy human controls. In skin fibroblasts from three patients with CTX, 26- hydroxylation of C27steroids was almost completely deficient.
Methods

Materials
Clinical. We studied two Norwegian sisters with CTX (A.F., born 27 July 1941, and IJ., born 6 May 1935). Detailed records ofclinical findings and laboratory data have been published previously (5, 6, 12, 13) . Patient H.E. is a 58-yr-old black man with a history of tendon xanthomas that began in his teens. Over his lifetime, the xanthomas gradually enlarged and progressed to involve numerous extensor tendons on his hands, bilateral tibial tuberosities, and bilateral Achilles tendons. He was otherwise in good health until 1979, when he developed exertional angina pectoris. Cardiac catheterization revealed severe atherosclerotic disease oftwo coronary arteries, with complete occlusion ofthe distal left anterior descending artery. In 1981, he underwent cholecystectomy after an episode of pancreatitis associated wtih cholelithiasis and biliary duct dilatation. In 1984, a lesion was excised from one large, firm xanthoma in the distribution noted above; the patient also had bilateral corneal arcus, but no xanthelasmas. A left femoral bruit was present with mildly diminished peripheral pulses bilaterally. Neurological examination disclosed decreased distal reflexes consistent with a mild peripheral neuropathy. In all other respects, however, neurological examination, including intellectual function, was normal.
All laboratory values were normal including tests for hepatic, thyroid, and renal function, and the patient's fasting cholesterol was 181 mg/dl and triglycerides were 148 mg/dl. The patient's plasma cholestanol level, analyzed on an SP-1000 gas-liquid chromatographic column (Supelco, Inc., Bellefonte, PA) (14), was 2.24 mg/dl (normal, <1 mg/dl (1)). Sitosterol could not be detected. In duodenal bile, neutral sterols were composed of 89.8% cholesterol and 10.2% cholestanol; normally, the percentage of cholestanol is <0.2%. Distribution of bile acids in the bile sample was 22.7% taurocholic acid, 54.7% glycocholic acid, 13 .0% glycochenodeoxychoic acid, and 9.6% glycodeoxycholic acid.
Several biochemical parameters (i.e., elevated plasma and biliary cholestanol, relatively low plasma cholesterol in the presence of tendon xanthomas, and a low percentage ofchenodeoxycholic acid in bile acids) are consistent with the diagnosis ofCTX in H.E. The diagnosis is further supported clinically by the presence of severe tendon xanthomatosis and premature coronary artery disease. The patient did not have progressive deterioration of central or peripheral nervous system function, but this finding is not invariably present in CTX (1).
Labeled steroids. 5#-[2,2,3,_2H4]-7IB-3H-cholestane-3a,7a,12a-triol was synthesized as described previously (5) . 7Il-3H-5IB-Cholestane3a,7a,12a-triol (9.9 mCi/mmol), 7#-3H-5ft-cholestane-3a,7a-diol (6.7 mCi/mmol), 7#%3H-5-cholestene-3,-7a-diol (158 mCi/mmol) and 4-4C-7a-hydroxy4-cholesten-3-one (1.3 mCi/mmol) were synthesized as described previously (5, 6, 13) . All these compounds were purified by high performance liquid chromatography (HPLC) (see below) before use.
Unlabeled steroids. 5#-cholestane-3a,7a,12a,26-tetrol, 5ft-cholestane3a,7a,26-triol, 7a,26-dihydroxy-4-cholesten-3-one and 5-cholestene-3(0,7a,26-triol were synthesized chemically or biosynthetically as described previously (5, 6, 15, 16 The cells were grown and maintained as monolayers in tissue culture flasks (75 cm2) (Costar, Cambridge, MA) in MEM supplemented with 17% fetal calf serum. Penicillin (100 U/ml), streptomycin (100 ;g/ml), amphotericin (2 U/ml) and L-glutamine (1.5 ,mo1/ml) were added. The cells were harvested with trypsin after 5-10 passages, washed three times in isotonic salt solution, and stored as a pellet at -70'C for a short period before assay. The cells were resuspended in sucrose (0.25 mol/ liter) and frozen and thawed three times. By light microscopy, all cells in these suspensions were found to be disrupted. Incubations were performed as described below, and cells from one culture flask were used for each assay of 26-hydroxylation. Protein was determined by a Lowry method.
Assay of C2rsteroid 26-hydroxylase was performed in fibroblasts, essentially according to the method of Atsuta and Okuda (17) and as previously described (5). When not otherwise stated, incubations were performed at 37-C for 2 h in air, as follows: to albumin (final concentration 12 rmol/liter), the substrate was added dissolved in acetone (which was evaporated under a stream of nitrogen) followed by the additions of(mmol/liter): sucrose, 10; Hepes buffer (pH 7.4), 33; ATP, 5; potassium malate, 5; glucose-6-phosphate, 1; glucose-6-phosphate-dehydrogenase, 0.5 U; NADPH, 1.2; and MgCl2, 15 . The reaction was started by the addition of the frozen and thawn fibroblast suspension corresponding to a final protein concentration of 1.6-3.3 mg/ml. Termination of the incubation was achieved by adding 0.1 ml of Ha (1 mol/liter). Extractions were performed twice with ethyl acetate, and the solvent was evaporated with N2. The extent of the conversion was calculated from the sum of radioactivity in the product zone. The experiments were designed so that with normal fibroblasts, product label corresponding to -15.000 dpm was usually obtained. In some experiments, the extent of26-hydroxylation was detected by mass fragmentography (ref. 16 and Fig. 5 ). All determinations were done in duplicate, and the overall coefficient ofvariation for the analysis was 4.9%. Carnitine palmitoyl transferase was assayed according to Norum and Bremer (18) . Incubations in an atmosphere of 5% oxygen, 40% carbon monoxide, and 55% nitrogen were performed as described by Bjorkhem and Holmberg (19) .
Chromatography and mass spectrometry. Duodenal bile from the U. S. citizen H.E. was aspirated and analyzed for sterols and bile acids by reverse-phase high pressure liquid chromatography (HPLC) by Dr. Lyman Bilhartz in Dallas, TX (20). A C-18 column with a pump and refractometer was employed. For neutral sterols, the mobile phase was 60% 2-propanol, 30% 0.6 M acetate buffer, pH 4.5. For the assay of 26-hydroxylase, aliquots of the extract of the different incubation mixtures were subjected to HPLC. A Supelcosil-LC18 column (250 X 4.6 mm, Combined gas chromatography. Mass spectrometry was performed with an LKB 9000 instrument (LKB Instruments, Inc., Gaithersburg, MD) equipped with a 1.5% SE30 capillary column. 5ft-cholestane3a,7a,12a,26-tetrol was identified by a complete mass spectrum (Fig.  1) , whereas the identity of the other 26-hydroxylated products was established by monitoring of selected typical ions (15) using a multiple ion detector (see ref. 16 ). Endogenous 5j3-choltestane-3a,7a,12a-triol was quantitated by isotope dilution-mass spectrometry with use of2H4-labeled 5#-cholestane-3a,7a,12a-triol and monitoring the ions at mass to charge ratio (m/e) 456 and 460 according to the same principles as described previously (5) .
Quantitation ofendogenous intermediates in thefibroblasts. Unincubated aliquots of skin fibroblast suspensions (0.5-1 mg of protein) from two CTX subjects (I.J. and H.E.) and two normal controls were each added to 0.1 yIg of 2H4-7#-3H-5#-cholestane-3a,7a,12a-triol at 00C and immediately extracted as described for cells incubated with substrates (see above). The extracts were subjected to HPLC, and the fractions containing 3H were pooled. The steroids were converted to trimethylsilyl (TMS) ethers with bis (trimethylsilyl) trifluoroacetamide (BSTFA) and analyzed by isotope dilution mass spectrometry as described above.
Results
During incubations of frozen and thawed normal skin fibroblasts with 5(#-cholestane-3a,7a,12a-triol (Rt, 38 min in the present HPLC system) and a NADPH-regenerating system, a polar product (Rt, 11 min) was formed. Fig. 1 shows that the mass spectrum of the isolated product (bottom) was identical to that of 5jB-cholestane-3a,7a,12a,26-tetrol used as reference (top). Note that under the gas-chromatographic conditions employed, 5,-cholestane-3a,7a,12a,26-tetrol was almost completely separated from 5jB-cholestane-3a,7a, 12a,25-tetrol and completely separated from 5B-cholestane-3a,7a,,12a,24-tetrol and 5#-cholestane-3a,7a,12a,23-tetrol (see ref. 16 ). The complete absence of 5#-cholestane-3a,7a,12a,25-tetrol in the isolated material was 1oo0. hydroxylase was studied by incubation also of 5f3-cholestane3a,7a-diol, 7a-hydroxy-4-cholesten-3-one and 7a-hydroxycholesterol with skin fibroblast suspensions.
The product obtained after incubation with 5fl-cholestane3a,7a-diol was purified by HPLC, converted into TMS ether, and analyzed by combined gas chromatography mass spectrometry. Due to the small amounts available, no complete mass spectrum of the compound could be obtained. However, the identity of the compound as TMS ether of 5,3-cholestane3a,7a,26-triol was established by selected monitoring ofthe typical ions at m/e 546 (M-90), 531 (M-90-15), and 441 (M-2X90-15) (15). All these tracings gave a peak with a retention time identical to that obtained with authentic 5(3-cholestane-3a,7a,26-triol. The purified product obtained after incubation with 7a-hydroxy-4-cholesten-3-one was also identified by combined gas chromatography-mass spectrometry, using selected ion monitoring of the trimethylsilyl ether derivative. The typical ions at m/e 545 (M-15), m/e 470 (M-90), and m/e 380 (M-2X90) were used (15) . All these tracings gave a peak with a retention time identical to that of derivative of authentic 7a,26-dihydroxy-4-cholesten-3-one isolated after incubation of 7a-hydroxy-4-cholesten-3-one with rat liver mitochondria (15) .
The trimethylsilyl ether of the product isolated after incubation of 7a-hydroxycholesterol was analyzed by selected monitoring of the ions at m/e 634 (M), 544 (M-90), 529 (M-90-15), and 454 (M-2X90) (15) . All the tracings gave a peak with a retention time identical to that of TMS ether of authentic 5-cholestene-3lB7a,26-triol. In addition, however, a peak with a slightly longer retention time was obtained in some tracings, indicating also that another product than 5-cholestene-3fl,7a,26-triol may have been formed. No attempts were made to identify this product. These results should be interpreted with caution, inter alia because of the restricted water solubility of the substrates. In addition, the rate of 26-hydroxylation of 7a-hydroxycholesterol may have been overestimated due to the presence of the additional compound in the product fraction. Michaelis constant (Ki) increased in the order 50-cholestane-3a,7a, 12a-triol < 7a-hydroxy4-cholesten-3-one < 5ft-cholestane-3a,7a-diol < 5-cholesten-3/3,7a-diol. The highest rate of 26-hydroxylation was observed with 7a-hydroxy-4-cholesten-3-one. A LineweaverBurk plot of the 26-hydroxylation of this substrate is shown by Fig. 4 . on HPLC. Table II shows 26-hydroxylation of 5#-cholestane-3a,7a,12a-triol in skin fibroblasts from three patients with cerebrotendinous xanthomatosis (I.J., A.F., and H.E.). In fibroblasts from all three CTX-subjects, 26-hydroxylation was deficient, and proceeded at a rate of only 0.2-2.5% of the controls. By isotope dilution mass spectrometry, the concentration of endogenous 5#-cholestane-3a,7a, 12a-triol was found to be lower than 6 ng/mg of protein in the cells from CTX-patients and healthy controls.
Since this was only 1/1,000 of added, labeled triol, the lowered formation of radioactive 5#-cholestane-3a,7a, 12a-triol from the CTX-subjects could not be explained by dilution of the labeled exogenous substrate. Fibroblasts from CTX patient I.J. were tested also with 5a-cholestane-3a,7a-diol and 7a-hydroxy-4-cholesten-3-one, and the 26-hydroxylase activity was <3% of the controls also with these substrates (Table II) . The experiments shown in Table II were based upon the detection of labeled product by the described HPLC method (see Methods), which separated the products very efficiently from the substrates (e.g., for 5g3-cholestane-3a,7a,12a,26-tetrol and 5l#-cholestane-3a,7a, 12a-triol, the R. were 11 and 38 min, respectively). Fig. 5 shows another method for the detection of product. Cells from CTX subject A.F. and control cells were incubated with 5#3-cholestane-3a,7a, 12a-triol, and the TMS ether of the isolated product was detected by a mass fragmentographic recording at m/e 253 (see ref. 16 ). After incubation of the triol with control cells, significant amounts of 5fl-cholestane-3a,7a, 12a,26-tetrol were detected, whereas 26-hydroxylated product hardly could be identified with cells from CTX subject A.F.
It is possible that the cells from the CTX patients had been inactivated before or during the incubations, in contrast with all normal controls tested. Further, the 26-hydroxylase of the skin biopsy from CTX subject H.E. might theoretically have been selectively inactivated in shipment from the United States. However, skin biopsies were taken from two control subjects in Dallas at the same time the biopsy was made on H.E. The biopsies were handled in the same manner both for the CTX patient H.E. and the controls, and they were sent and studied blindly. Table II shows separate results for the American controls, whose 26-hydroxylation capacity was within the observed normal range.
In a parallel assay of A5-3f3-hydroxysteroid dehydrogenase with 5-cholestene-3fl,7a-diol as substrate, this enzymatic activity could easily be detected in normal cells from the control subjects and was not lowered in fibroblasts from any of the three CTX subjects (results not shown). Further, the inner mitochondrial membrane marker enzyme, carnitine palmitoyl tsferase (18) , had similar activity in the cells from all three CTX patients and the healthy human controls (Table III) .
Discussion
Presence in human skin fibroblasts of enzymes acting on bile acid intermediates. In this study, we have shown C2rsteroid 26- hydroxylase activity in human skin fibroblasts. All cultures derived from healthy subjects that were tested had such activity, which was strongly inhibited by CO. Also, C2rA5-3#-hydroxysteroid dehydrogenase was present in normal fibroblasts. The activity of C27-steroid 26-hydroxylase in frozen and thawed fibroblasts from healthy human subjects was -5-10% of that previously found in total homogenates of human liver (5) . In the liver, the 26-hydroxylase is present in the mitochondria (5, 17, 21) , where it is localized in the inner membrane. In human liver, there is little or no 26-hydroxylation in the microsomal fraction (21). In the rat, on the other hand, 26-hydroxylation (18) . The assays were performed with two different protein concentrations in the assays; both series are shown.
* Skin biopsies were sent from the United States by the same shipment.
occurs both in the mitochondrial and the microsomal fraction (21). Our attempts to isolate different subcellular fractions ofcultured human skin fibroblasts have failed so far, and we cannot be sure that we have assayed the mitochondrial 26-hydroxylase. However, it is interesting to compare the present results with known properties of the mitochondrial and microsomal hydroxylases. We found that the 26-hydroxylase of human skin fibroblasts has a low substrate specificity, as has the mitochondrial 26-hydroxylase (21). The affinities of the enzyme for the substrates tested decreased in this order: 5(3-cholestane-3a,7a, 12a-triol > 7a-hydroxy-4-cholesten-3-one > 5fl-cholestane-3a,7a-diol, which is also the case for the mitochondrial 26-hydroxylase in the liver (21). We observed the highest rate of26-hydroxylation with 7a-hydroxy-4-cholesten-3-one. The apparent Km for 5fl-cholestane-3a,7a, 12a-triol found in the present study (1.3 gmol/ liter) is closer to values previously found in liver mitochondria (4.5-7.1 smol/liter) (5, 17) than in liver microsomes (15 smol/ liter) (5). The latter 26-hydroxylase, furthermore, has a much higher substrate specificity than the mitochondrial enzyme, and is only active to a significant extent with 5ft-cholestane3a,7a, 12a-triol as substrate. Thus, the properties of the activity we studied resemble mitochondrial 26-hydroxylase more than the microsomal enzyme.
26-Hydroxjlated C27-steroids in serum, brain, and atheromata. The major part of the 26-hydroxylation of C27-steroids probably occurs in liver mitochondria (21). 26-Hydroxycholesterol has been identified in human meconium, in serum from normal adults (22) , and in brain (23) . Further, 26-hydroxycholesterol has been isolated from human atheromata, where it is probably not a product of autoxidation. It has been suggested that it may be accumulated from plasma (24) . The present finding of 26-hydroxylation of C2rsteroids in fibroblasts from healthy controls shows that such enzymatic activity may be expressed in some other organs than the liver.
It has been proposed that hydroxylated sterols may be involved in the normal regulation of cellular sterol metabolism (25) , but direct evidence for this concept is lacking. 26-Hydroxycholesterol is reduced or absent in serum from patients with CTX (26) . It may be speculated that 26-hydroxylation normally occurs also in some extrahepatic tissues and participates in the regulation of sterol metabolism. In CTX patients, however, extrahepatic 26-hydroxylation will probably not occur, as suggested by the present findings. At this time, it is difficult to see how an extrahepatic absence ofthis enzymatic activity in CTX can contribute to the accumulation of sterols in the central nervous system and to the premature atherosclerosis in this disease. Enzymic defect in CTX. In this study we showed with cultured skin fibroblasts from three subjects with CTX, that 26-hydroxylation of 5(#-cholestane-3a,7a,12a-triol was deficient, proceeding at a rate of only 0.2-2.5% of normal controls. Deficiency of 26-hydroxylation could also be demonstrated with 5f-cholestane-3a,7a-diol, 7a-hydroxy-4-cholesten-3-one, and 5-cholestene-3jS,7a-diol.
This finding adds strong evidence to our concept that the primary enzymatic defect in CTX is a deficiency of Cr-steroid 26-hydroxylase. Moreover, it appears that the two Norwegian sisters with CTX studied by us (5, 6, 12, 13) do not suffer from a particular genetic variant of the disaese, since the deficiency of 26-hydroxylase was also found in skin fibroblasts from an American CTX-patient.
